These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 29957287)

  • 1. NT-proBNP in stable COPD and future exacerbation risk: Analysis of the SPIROMICS cohort.
    Labaki WW; Xia M; Murray S; Curtis JL; Barr RG; Bhatt SP; Bleecker ER; Hansel NN; Cooper CB; Dransfield MT; Wells JM; Hoffman EA; Kanner RE; Paine R; Ortega VE; Peters SP; Krishnan JA; Bowler RP; Couper DJ; Woodruff PG; Martinez FJ; Martinez CH; Han MK
    Respir Med; 2018 Jul; 140():87-93. PubMed ID: 29957287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma N-terminal pro-brain natriuretic peptide: a prognostic marker in patients with chronic obstructive pulmonary disease.
    Chi SY; Kim EY; Ban HJ; Oh IJ; Kwon YS; Kim KS; Kim YI; Kim YC; Lim SC
    Lung; 2012 Jun; 190(3):271-6. PubMed ID: 22246552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phenotyping COPD exacerbations using imaging and blood-based biomarkers.
    Alotaibi NM; Chen V; Hollander Z; Hague CJ; Murphy DT; Leipsic JA; DeMarco ML; FitzGerald JM; McManus BM; Ng RT; Sin DD
    Int J Chron Obstruct Pulmon Dis; 2018; 13():217-229. PubMed ID: 29386890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic Role of NT-proBNP for in-Hospital and 1-Year Mortality in Patients with Acute Exacerbations of COPD.
    Li H; Zeng Z; Cheng J; Hu G; Li Y; Wei L; Zhou Y; Ran P
    Int J Chron Obstruct Pulmon Dis; 2020; 15():57-67. PubMed ID: 32021144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Short-term treatment of irbesartan and hydrochlorothiazide decreases plasma N-terminal pro-brain natriuretic peptide levels in subjects with acute exacerbations of COPD.
    Jiang GY; Li Q; Lv YX
    Int J Chron Obstruct Pulmon Dis; 2019; 14():73-80. PubMed ID: 30587963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NT-proBNP independently predicts long term mortality after acute exacerbation of COPD - a prospective cohort study.
    Høiseth AD; Omland T; Hagve TA; Brekke PH; Søyseth V
    Respir Res; 2012 Oct; 13(1):97. PubMed ID: 23107284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NT-proBNP in Different Patient Groups of COPD: A Systematic Review and Meta-Analysis.
    Su X; Lei T; Yu H; Zhang L; Feng Z; Shuai T; Guo H; Liu J
    Int J Chron Obstruct Pulmon Dis; 2023; 18():811-825. PubMed ID: 37197601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frequency of exacerbations in patients with chronic obstructive pulmonary disease: an analysis of the SPIROMICS cohort.
    Han MK; Quibrera PM; Carretta EE; Barr RG; Bleecker ER; Bowler RP; Cooper CB; Comellas A; Couper DJ; Curtis JL; Criner G; Dransfield MT; Hansel NN; Hoffman EA; Kanner RE; Krishnan JA; Martinez CH; Pirozzi CB; O'Neal WK; Rennard S; Tashkin DP; Wedzicha JA; Woodruff P; Paine R; Martinez FJ;
    Lancet Respir Med; 2017 Aug; 5(8):619-626. PubMed ID: 28668356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biochemical markers of cardiac dysfunction predict mortality in acute exacerbations of COPD.
    Chang CL; Robinson SC; Mills GD; Sullivan GD; Karalus NC; McLachlan JD; Hancox RJ
    Thorax; 2011 Sep; 66(9):764-8. PubMed ID: 21474497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-terminal fragment of the prohormone brain-type natriuretic peptide (NT-proBNP), cardiovascular events, and mortality in patients with stable coronary heart disease.
    Bibbins-Domingo K; Gupta R; Na B; Wu AH; Schiller NB; Whooley MA
    JAMA; 2007 Jan; 297(2):169-76. PubMed ID: 17213400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Correlation between N-terminal probrainnatriuretic peptide and prognosis of acute exacerbations of chronic obstructive pulmonary disease].
    Zhao CL; Zhang QR; Huang JW; Zhang L; Zhou M
    Zhonghua Jie He He Hu Xi Za Zhi; 2018 Feb; 41(2):95-99. PubMed ID: 29429214
    [No Abstract]   [Full Text] [Related]  

  • 12. Prognostic and diagnostic significance of mid-regional pro-atrial natriuretic peptide in acute exacerbation of chronic obstructive pulmonary disease and acute heart failure: data from the ACE 2 Study.
    Pervez MO; Winther JA; Brynildsen J; Strand H; Christensen G; Høiseth AD; Myhre PL; Røysland R; Lyngbakken MN; Omland T; Røsjø H
    Biomarkers; 2018 Nov; 23(7):654-663. PubMed ID: 29733687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in biomarkers of cardiac dysfunction during exacerbations of chronic obstructive pulmonary disease.
    Shafuddin E; Chang CL; Cooray M; Tuffery CM; Hopping SJ; Sullivan GD; Jacobson GA; Hancox RJ
    Respir Med; 2018 Dec; 145():192-199. PubMed ID: 30509708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N-Terminal Prohormone of Brain Natriuretic Peptide (NT-proBNP) as a Diagnostic Biomarker of Left Ventricular Systolic Dysfunction in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease (AECOPD).
    Andrijevic I; Milutinov S; Lozanov Crvenkovic Z; Matijasevic J; Andrijevic A; Kovacevic T; Bokan D; Zaric B
    Lung; 2018 Oct; 196(5):583-590. PubMed ID: 29951921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictive value of NT-proBNP in vascular surgery patients with COPD and normal left ventricular systolic function.
    van Gestel YR; Goei D; Hoeks SE; Sin DD; Flu WJ; Stam H; Mertens FW; Bax JJ; van Domburg RT; Poldermans D
    COPD; 2010 Feb; 7(1):70-5. PubMed ID: 20214466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ratio of FEV
    Fortis S; Comellas AP; Bhatt SP; Hoffman EA; Han MK; Bhakta NR; Paine R; Ronish B; Kanner RE; Dransfield M; Hoesterey D; Buhr RG; Barr RG; Dolezal B; Ortega VE; Drummond MB; Arjomandi M; Kaner RJ; Kim V; Curtis JL; Bowler RP; Martinez F; Labaki WW; Cooper CB; O'Neal WK; Criner G; Hansel NN; Krishnan JA; Woodruff P; Couper D; Tashkin D; Barjaktarevic I
    Chest; 2021 Jul; 160(1):94-103. PubMed ID: 33539837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiac biomarkers retain prognostic significance in patients with heart failure and chronic obstructive pulmonary disease.
    Vergaro G; Aimo A; Januzzi JL; Richards AM; Lam CSP; Latini R; Staszewsky L; Anand IS; Ueland T; Rocca HB; Bayes-Genis A; Lupón J; de Boer RA; Yoshihisa A; Takeishi Y; Gustafsson I; Eggers KM; Huber K; Gamble GD; Leong KTG; Yeo PSD; Ong HY; Jaufeerally F; Ng TP; Troughton R; Doughty RN; Emdin M; Passino C
    J Cardiovasc Med (Hagerstown); 2022 Jan; 23(1):28-36. PubMed ID: 34839321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. N-terminal proB-type natriuretic peptide levels aid the diagnosis of left ventricular dysfunction in patients with severe acute exacerbations of chronic obstructive pulmonary disease and renal dysfunction.
    Ouanes I; Jalloul F; Ayed S; Dachraoui F; Ouanes-Besbes L; Fekih Hassen M; Elatrous S; Abroug F
    Respirology; 2012 May; 17(4):660-6. PubMed ID: 22348741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inflammatory biomarkers and exacerbations in chronic obstructive pulmonary disease.
    Thomsen M; Ingebrigtsen TS; Marott JL; Dahl M; Lange P; Vestbo J; Nordestgaard BG
    JAMA; 2013 Jun; 309(22):2353-61. PubMed ID: 23757083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NT-proBNP and Echocardiographic Parameters for Prediction of Cardiovascular Outcomes in Patients with CKD Stages G2-G4.
    Untersteller K; Girerd N; Duarte K; Rogacev KS; Seiler-Mussler S; Fliser D; Rossignol P; Heine GH
    Clin J Am Soc Nephrol; 2016 Nov; 11(11):1978-1988. PubMed ID: 27515593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.